Atara Biotherapeutics (ATRA) Share-based Compensation (2013 - 2026)
Atara Biotherapeutics' Share-based Compensation came in at $394,000 for Q2 2026, down 85.9% from $2.8 million a year earlier and down 47.4% from the prior quarter.
Powered by 
Analysis
Atara Biotherapeutics (ATRA) Share-based Compensation (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Atara Biotherapeutics reported Share-based Compensation of $3.89 million, down 79.8% year-over-year; for FY2025, it came in at $9.75 million, down 63.9% from FY2024.
- Share-based Compensation has declined in each of the last four years, with a five-year compound annual growth rate of -28.3% (FY2020 to FY2025).
- Going back by year, Share-based Compensation was $27 million in FY2024 (-40.5%), $45.39 million in FY2023 (-15.7%), $53.84 million in FY2022 (-0.1%) and $53.87 million in FY2021 (+4.9%).
- The Q2 2026 figure represents the lowest quarterly Share-based Compensation in data going back to Q4 2013.
- Year-over-year, Share-based Compensation has declined for 15 consecutive quarters, with an average decline of 64.0% over the last eight quarters.
- The fastest year-over-year change in Share-based Compensation over five years came in Q4 2021 (growth of 21.9%), and the weakest in Q2 2026 (a decline of 85.9%).
- Business Quant data shows ATRA's Share-based Compensation at $749,000 (Q1 2026), $1.52 million (Q4 2025) and $1.23 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Atara Biotherapeutics | 127.78 Mn | 117.88 Mn | 439,000.00 | 394,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 394,000.00 |
| Mar 31, 2026 | 749,000.00 |
| Dec 31, 2025 | 1.52 Mn |
| Sep 30, 2025 | 1.23 Mn |
| Jun 30, 2025 | 2.80 Mn |
| Mar 31, 2025 | 4.21 Mn |
| Dec 31, 2024 | 5.85 Mn |
| Sep 30, 2024 | 6.42 Mn |
| Jun 30, 2024 | 6.34 Mn |
| Mar 31, 2024 | 8.40 Mn |
| Dec 31, 2023 | 9.93 Mn |
| Sep 30, 2023 | 11.14 Mn |
| Jun 30, 2023 | 12.55 Mn |
| Mar 31, 2023 | 11.76 Mn |
| Dec 31, 2022 | 11.36 Mn |
| Sep 30, 2022 | 14.02 Mn |
| Jun 30, 2022 | 14.12 Mn |
| Mar 31, 2022 | 14.34 Mn |
| Dec 31, 2021 | 14.03 Mn |
| Sep 30, 2021 | 13.76 Mn |
API Access
Atara Biotherapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ATRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ATRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ATRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();